Ellen Snow

CIK 1786643 · SVP, CFO and Treasurer · last filed 2024-02-02

Ellen Snow is a SVP, CFO and Treasurer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for AKBA, was dated Feb 2, 2024. Across all open-market trades the lifetime net is −$9.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $594.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$594.6K

Companies

3

Total Filings

8

Lifetime Open-Market Net

-$9.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AKBA	SVP, CFO and Treasurer	519,300	$1.15	$594.6K	$0	2	2024-02-02
Pear Therapeutics, Inc. (PEARW) Delisted	VP, Chief Accounting Officer	23,318	$0.01	$138	-$9.1K	5	2023-02-17
AlerisLife Inc. (FVE) Delisted	Chief Accounting Officer	2,500	$2.94	$7.3K	$0	1	2020-12-16

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-02-02	AKBA	Grant (A)	+149,300	$0	EDGAR
2023-08-01	AKBA	Grant (A)	+370,000	$0	EDGAR
2023-02-17	Pear Therapeutics, Inc. (PEARW) Delisted	Grant (A)	—	$0	EDGAR
2023-01-24	Pear Therapeutics, Inc. (PEARW) Delisted	Sell (S)	−8,027	-$9.1K	EDGAR
2023-01-18	Pear Therapeutics, Inc. (PEARW) Delisted	Exer (M)	+20,320	$0	EDGAR
2022-02-18	Pear Therapeutics, Inc. (PEARW) Delisted	Grant (A)	—	$0	EDGAR
2021-12-07	Pear Therapeutics, Inc. (PEARW) Delisted	Grant (A)	—	$0	EDGAR
2020-12-16	AlerisLife Inc. (FVE) Delisted	Grant (A)	+2,500	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.